Hope Discovered Here®
Creating a world without heart and vascular disease
We are the Minneapolis Heart Institute Foundation® (MHIF).
For more than 37 years, we’ve been a world-class cardiovascular research and education organization committed to making the impossible possible for our patients.
Patients are at the heart of our mission. We provide:
•Hope for patients, improving their well-being and life expectancy
•Hope for their children, siblings, parents and families
•Hope for new treatment options
•Hope for a world without heart and vascular disease
Benefits of Participating in Research
Every year, exciting breakthroughs and new discoveries stem from our research. These important findings advance medical knowledge, improving the health and lives of millions of people worldwide.
Be More Active
Potential to Unlock More Options
Make a Contribution
Find Clinical Research Trials
Read Our Latest News
Minneapolis Heart Institute Foundation Participates in Research to Expand Availability of Donor Heart Transplants Through Use of New Technology
MHIF is one of eight sites to enroll patients evaluating new organ care system designed to ensure viability of more donor hearts for patients in need.
On Aug. 18, 2020, we held our virtual Founder’s Event celebrating the vision and philanthropic leadership of MHIF’s founding physicians, community leaders and their families, each a vitally important part of MHIF.
KSTP: Historic gift to the Minneapolis Heart Institute Foundation to help prevent heart attacks, strokes
KSTP interviewed Kristine Fortman, PhD, MHIF CEO and Dr. Micheal Miedema, MD, MPH, Director, Nolan Family Center for Cardiovascular Health.
Join Us at Upcoming Events
Gather your favorite women and join us for an evening of Hope, Health & Humor.
THANK YOU Another successful MHIF Founder’s Event at the Minikahda Club! A night spent reminiscing and celebrating the history, growth, accomplishments, and continued mission of innovative research and education at the Minneapolis Heart...
Agenda: 5:00-6:00PM Registration, dinner & exhibits 6:00-6:10PM Welcome – David Hurrell, MD 6:10-6:30PM The Role of PCSK9 Inhibitors & Clinical Update - Thomas Knickelbine, MD 6:30-6:50PM Incorporating PCSK9 Inhibitors into a Risk-based Approach...